Biofrontera Ag Asset Turnover Ratio (BFRA), as of fourth quarter 2018, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biofrontera Ag  (BFRA)
 

Biofrontera Ag Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Biofrontera Ag asset turnover ratio, the ability of Biofrontera Ag's assets to generate revenue in the fourth quarter 2018, increased sequentially to 0.54 in the fourth quarter (Dec 31 2018), yet the ratio remained below the average, as BFRA's position remain challenging.

Within sector 100 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2018 compared to the preceding quarter from 0 to 2343.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BFRA Asset Turnover Ratio (Dec 31 2018)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Asset Change 120.82 % 120.82 % 120.82 % 120.82 % -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.54 - - - -
BFRA's Total Ranking # 2343 # 0 # 0 # 0 # 0
Seq. Asset Change 0 % 0 % 0 % 120.82 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 101
Healthcare Sector # 250
Overall Market # 2343

Asset Turnover Ratio Statistics
High Average Low
6.64 6.64 6.64
(Dec 31 2018)  




BFRA Company Profile • Back to BFRA Efficiency Comparisons • Compare BFRA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Assets at quarter ending Dec 31 2018
Tactile Systems Technology Inc   1.48 $ 143.751  Millions$ 97.153  Millions
Stereotaxis Inc   1.48 $ 29.347  Millions$ 19.858  Millions
Cutera Inc   1.48 $ 162.720  Millions$ 110.108  Millions
Addus Homecare Corp  1.48 $ 518.119  Millions$ 350.611  Millions
Idexx Laboratories Inc  1.46 $ 2,213.242  Millions$ 1,518.014  Millions
Vaso Corporation  1.46 $ 73.980  Millions$ 50.799  Millions
Rennova Health Inc   1.43 $ 19.962  Millions$ 14.004  Millions
Quorum Health Corporation  1.42 $ 2,339.096  Millions$ 1,650.765  Millions
American Bio Medica Corporation  1.42 $ 3.872  Millions$ 2.734  Millions
Misonix Inc   1.38 $ 40.613  Millions$ 29.473  Millions
Rockwell Medical inc   1.38 $ 63.389  Millions$ 46.004  Millions
Genomic Health Inc  1.37 $ 394.111  Millions$ 286.673  Millions
Alpha Pro Tech Ltd   1.37 $ 46.624  Millions$ 33.977  Millions
Fuse Medical Inc   1.37 $ 26.342  Millions$ 19.208  Millions
International Stem Cell Corporation  1.37 $ 11.089  Millions$ 8.101  Millions
Yunhong Green Cti Ltd   1.36 $ 55.591  Millions$ 40.773  Millions
Neurometrix Inc   1.34 $ 16.090  Millions$ 11.983  Millions
Omnova Solutions Inc  1.33 $ 769.900  Millions$ 578.200  Millions
Earth Science Tech Inc   1.32 $ 0.666  Millions$ 0.503  Millions
Harrow Inc   1.32 $ 41.372  Millions$ 31.317  Millions
Itamar Medical Ltd   1.32 $ 24.189  Millions$ 18.392  Millions
Aeon Global Health Corp.  1.31 $ 14.698  Millions$ 11.188  Millions
Scientific Industries Inc   1.30 $ 9.510  Millions$ 7.330  Millions
Phibro Animal Health Corporation  1.25 $ 839.070  Millions$ 673.169  Millions
Biolase Inc   1.24 $ 46.155  Millions$ 37.201  Millions
Hca Healthcare Inc   1.23 $ 46,677.000  Millions$ 38,073.000  Millions
Irhythm Holdings Inc   1.22 $ 147.293  Millions$ 120.485  Millions
Universal Health Services Inc   1.22 $ 13,560.680  Millions$ 11,158.000  Millions
Vycor Medical Inc   1.19 $ 1.509  Millions$ 1.271  Millions
Electromed Inc   1.17 $ 30.620  Millions$ 26.264  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.